RESEARCH-USE BIOSIMILAR ANTIBODY

Tucotuzumab

Antibody-drug conjugate · IgG1

EPCAMIgG1RUO

Tucotuzumab (Anti-EPCAM Recombinant Antibody) is an antigen-specific IgG1 monoclonal antibody that targets human epithelial cell adhesion molecule (EpCAM). Tucotuzumab links two IL-2 molecules and is an immunosuppressant and anti-tumor active molecule.

TARGETEPCAM
YAntibody-drug conjugate
CATALOGSC-BS-085
CATALOG NUMBERSC-BS-085
MOLECULAR WEIGHTApprox. 144.34 kDa
PRODUCT FORMATAntibody-drug conjugate

A research-use configuration for comparative antibody studies

Tucotuzumab (Anti-EPCAM Recombinant Antibody) is an antigen-specific IgG1 monoclonal antibody that targets human epithelial cell adhesion molecule (EpCAM). Tucotuzumab links two IL-2 molecules and is an immunosuppressant and anti-tumor active molecule.

Tucotuzumab is a recombinant research-use antibody directed against EPCAM.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Tucotuzumab | StellaCyte